Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Evaluation of a Virtual Reality Tool for Identifying the Cognitive Functions of the Right Hemisphere in Patients With Glioma -TANGO (TANGO)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04288505
Recruitment Status : Recruiting
First Posted : February 28, 2020
Last Update Posted : June 4, 2020
Sponsor:
Information provided by (Responsible Party):
University Hospital, Angers

Brief Summary:
Evaluate the diagnostic performance of a virtual reality application to detect the presence of cognitive impairment of the non-dominant hemisphere in patients with glioma

Condition or disease Intervention/treatment Phase
Brain Tumor Virtual Reality Diagnostic Test: VIRTUAL REALITY application Not Applicable

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 36 participants
Allocation: N/A
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Diagnostic
Official Title: Evaluation of a Virtual Reality Tool for Identifying the Cognitive Functions of the Right Hemisphere in Patients With Glioma -TANGO
Actual Study Start Date : May 28, 2020
Estimated Primary Completion Date : February 20, 2024
Estimated Study Completion Date : March 1, 2024

Resource links provided by the National Library of Medicine


Arm Intervention/treatment
Experimental: single arm Diagnostic Test: VIRTUAL REALITY application
application on virtual reality headset




Primary Outcome Measures :
  1. PERFORMANCE OF the VR APPLICATION compared to classic cognitive tests batery for the detection of cognitive deficit [ Time Frame: from surgery to 3 months after surgery ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Indication for glioma surgery
  • Karnofsky > 70

Exclusion Criteria:

-


Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04288505


Contacts
Layout table for location contacts
Contact: Jean Michel Lemee +33241356786 JMLemee@chu-angers.fr

Locations
Layout table for location information
France
University hospital Recruiting
Angers, France, 49000
Contact: Jean Michel LEMEE    +33241356786    JMLemee@chu-angers.fr   
Sponsors and Collaborators
University Hospital, Angers
Layout table for additonal information
Responsible Party: University Hospital, Angers
ClinicalTrials.gov Identifier: NCT04288505    
Other Study ID Numbers: 2020-A00074-35
First Posted: February 28, 2020    Key Record Dates
Last Update Posted: June 4, 2020
Last Verified: April 2020
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Additional relevant MeSH terms:
Layout table for MeSH terms
Brain Neoplasms
Neoplasms
Central Nervous System Neoplasms
Nervous System Neoplasms
Neoplasms by Site
Brain Diseases
Central Nervous System Diseases
Nervous System Diseases